Valuation: QuidelOrtho Corporation

Capitalization 1.89B 1.62B 1.52B 1.42B 2.61B 170B 2.84B 17.76B 6.86B 80.16B 7.08B 6.93B 293B P/E ratio 2025 *
-1.83x
P/E ratio 2026 * -36x
Enterprise value 4.13B 3.55B 3.33B 3.1B 5.73B 372B 6.23B 38.92B 15.03B 176B 15.51B 15.18B 642B EV / Sales 2025 *
1.53x
EV / Sales 2026 * 1.4x
Free-Float
98.54%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.22%
1 week+1.50%
Current month+1.50%
1 month+36.41%
3 months-3.21%
6 months-5.99%
Current year-37.69%
More quotes
1 week 26.31
Extreme 26.31
28.3
1 month 19.5
Extreme 19.5
28.37
Current year 19.5
Extreme 19.5
49.45
1 year 19.5
Extreme 19.5
49.45
3 years 19.5
Extreme 19.5
102
5 years 19.5
Extreme 19.5
265
10 years 13.21
Extreme 13.2105
306.72
More quotes
Manager TitleAgeSince
Chief Executive Officer 60 2024-05-05
Director of Finance/CFO 58 -
Chief Operating Officer 56 2024-11-14
Director TitleAgeSince
Chairman 71 2022-12-10
Director/Board Member 70 2021-12-31
Director/Board Member 81 1992-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.22%+1.50%-27.33%-70.02% 1.89B
-1.05%+1.35%+19.81%-28.38% 18.11B
+7.09%+3.81%+81.76%+265.69% 2.63B
+0.32%-4.27%-1.92%-5.48% 1.13B
+1.75%+0.87%+1.19%-28.82% 908M
+0.44%-3.64%-1.18%-39.64% 904M
+1.61%-0.67%-19.45%-44.62% 686M
-1.59%+29.21%+363.91% - 558M
+0.35%+0.09%-26.34%-42.22% 483M
-0.64%-5.22%-24.90%-27.69% 396M
Average +0.81%+1.94%+36.55%-2.35% 2.77B
Weighted average by Cap. +0.06%+1.30%+24.83%-2.82%
See all sector performances

Financials

2025 *2026 *
Net sales 2.71B 2.33B 2.18B 2.03B 3.75B 244B 4.08B 25.5B 9.84B 115B 10.16B 9.94B 421B 2.77B 2.38B 2.23B 2.08B 3.84B 249B 4.18B 26.08B 10.07B 118B 10.39B 10.17B 430B
Net income -1.03B -886M -830M -774M -1.43B -92.81B -1.56B -9.71B -3.75B -43.83B -3.87B -3.79B -160B -52.74M -45.34M -42.47M -39.58M -73.11M -4.75B -79.53M -497M -192M -2.24B -198M -194M -8.2B
Net Debt 2.25B 1.93B 1.81B 1.69B 3.11B 202B 3.39B 21.15B 8.17B 95.46B 8.43B 8.25B 349B 1.99B 1.71B 1.6B 1.5B 2.76B 179B 3B 18.77B 7.25B 84.71B 7.48B 7.32B 310B
More financial data * Estimated data
Logo QuidelOrtho Corporation
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Employees
6,600
More about the company
Date Price Change Volume
25-12-05 27.76 $ -0.22% 705,720
25-12-04 27.82 $ +1.05% 788,046
25-12-03 27.53 $ +3.77% 1,146,621
25-12-02 26.53 $ +0.19% 879,799
25-12-01 26.48 $ -3.18% 746,964

Delayed Quote Nasdaq, December 05, 2025 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
27.76USD
Average target price
37.67USD
Spread / Average Target
+35.69%
Consensus

Quarterly revenue - Rate of surprise